| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762519257P | 2017-06-14 | 2017-06-14 | |
| US201862628582P | 2018-02-09 | 2018-02-09 | |
| US201862653942P | 2018-04-06 | 2018-04-06 | |
| US201862678387P | 2018-05-31 | 2018-05-31 | |
| PCT/US2018/037219WO2018231908A1 (en) | 2017-06-14 | 2018-06-13 | Methods for treating lung disorders |
| Publication Number | Publication Date |
|---|---|
| SG11201909837YAtrue SG11201909837YA (en) | 2019-11-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913400QASG10201913400QA (en) | 2017-06-14 | 2018-06-13 | Methods for treating lung disorders |
| SG11201909837YSG11201909837YA (en) | 2017-06-14 | 2018-06-13 | Methods for treating lung disorders |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913400QASG10201913400QA (en) | 2017-06-14 | 2018-06-13 | Methods for treating lung disorders |
| Country | Link |
|---|---|
| US (3) | US10398646B2 (en) |
| EP (1) | EP3615004B1 (en) |
| JP (2) | JP6840869B2 (en) |
| KR (2) | KR102303762B1 (en) |
| CN (2) | CN110799176A (en) |
| AU (2) | AU2018284247B2 (en) |
| BR (1) | BR112019022720A2 (en) |
| CA (1) | CA3063436A1 (en) |
| ES (1) | ES3015106T3 (en) |
| SG (2) | SG10201913400QA (en) |
| WO (1) | WO2018231908A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3302431B1 (en) | 2015-06-04 | 2020-11-11 | Crititech, Inc. | Taxane particles and their use |
| BR112018069628A2 (en) | 2016-04-04 | 2019-02-12 | Crititech, Inc. | solid tumor treatment methods |
| WO2018227037A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| CA3063436A1 (en) | 2017-06-14 | 2018-12-20 | Crititech, Inc. | Methods for treating lung disorders |
| CA3076919A1 (en) | 2017-10-03 | 2019-04-11 | Crititech, Inc. | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
| US20190365698A1 (en)* | 2018-05-31 | 2019-12-05 | Crititech, Inc. | Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer |
| SG11202008749UA (en)* | 2018-05-31 | 2020-10-29 | Crititech Inc | Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccines |
| WO2020072090A1 (en)* | 2018-10-03 | 2020-04-09 | Crititech, Inc. | Use of antineoplastic agents to stimulate the immune system for production of tertiary lymphoid structures (tls) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en)* | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
| GB9413202D0 (en) | 1994-06-30 | 1994-08-24 | Univ Bradford | Method and apparatus for the formation of particles |
| US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| US5874481A (en) | 1995-06-07 | 1999-02-23 | Alliance Pharmaceutical Corp. | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents |
| US5874029A (en) | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
| US5833891A (en) | 1996-10-09 | 1998-11-10 | The University Of Kansas | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents |
| US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| EP0954283B1 (en)* | 1996-12-30 | 2007-03-21 | Battelle Memorial Institute | Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation |
| NZ525580A (en) | 1997-06-27 | 2004-08-27 | Vivorx Pharmaceuticals Inc | Vehicles for intravenous administration of paclitaxel having reduced toxicity |
| US6117949A (en) | 1998-10-01 | 2000-09-12 | Macromed, Inc. | Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| JP3418751B2 (en) | 1998-01-22 | 2003-06-23 | 参天製薬株式会社 | Fluorometholone suspension ophthalmic solution |
| IL131217A0 (en) | 1998-03-10 | 2001-01-28 | Napro Biotherapeutics Inc | Novel methods and compositions for delivery of taxanes |
| US6221153B1 (en) | 1998-06-09 | 2001-04-24 | Trevor Percival Castor | Method for producing large crystals of complex molecules |
| US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| US6113795A (en) | 1998-11-17 | 2000-09-05 | The University Of Kansas | Process and apparatus for size selective separation of micro- and nano-particles |
| ES2193765T3 (en) | 1998-11-25 | 2003-11-01 | Universitaetsklinikum Freiburg | POMADA OR HYPERFORINE CREAM. |
| US6537585B1 (en) | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
| US7217735B1 (en) | 1999-04-09 | 2007-05-15 | Au Jessie L-S | Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| EP1180020B2 (en) | 1999-05-27 | 2009-06-24 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6610317B2 (en) | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
| US6858199B1 (en)* | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US6616849B1 (en) | 1999-08-25 | 2003-09-09 | Shimadzu Corporation | Method of and system for continuously processing liquid materials, and the product processed thereby |
| WO2001036007A2 (en) | 1999-11-12 | 2001-05-25 | Angiotech Pharmaceuticals, Inc. | Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| CA2393233A1 (en)* | 1999-12-04 | 2001-06-07 | Research Development Foundation | Carbon dioxide enhancement of inhalation therapy |
| US6620351B2 (en) | 2000-05-24 | 2003-09-16 | Auburn University | Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer |
| US6562952B1 (en) | 2000-10-31 | 2003-05-13 | The University Of Kansas | Precipitation of proteins from organic solutions |
| US20020081339A1 (en) | 2000-12-22 | 2002-06-27 | Philippe Menei | Treatment of inoperable tumors by stereotactic injection of microspheres |
| JP2004529934A (en) | 2001-05-01 | 2004-09-30 | アンジオテック ファーマシューティカルズ，インコーポレイテッド | Compositions comprising anti-microtubule agents and polypeptides or polysaccharides, and uses of those compositions for the preparation of a medicament for treating inflammatory conditions |
| ES2261469T5 (en) | 2001-07-02 | 2015-12-22 | Micro & Nano Materials Sagl | Process to produce micro and / or nanoparticles |
| EP1424889A4 (en)* | 2001-08-20 | 2008-04-02 | Transave Inc | Method for treating lung cancers |
| US20030054042A1 (en) | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| US20030134810A1 (en) | 2001-10-09 | 2003-07-17 | Chris Springate | Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents |
| JP2005508354A (en) | 2001-10-15 | 2005-03-31 | クリチテック インコーポレーテッド | Composition and method for delivering a drug which is hardly soluble in water, and method of treatment |
| JP2005511629A (en) | 2001-11-20 | 2005-04-28 | アドバンスト インハレーション リサーチ，インコーポレイテッド | Long-acting product delivery composition |
| EP1480691A4 (en) | 2002-03-05 | 2007-11-28 | Univ State Cleveland | AGGLOMERATED PARTICLES FOR ADMINISTERING AEROSOL DRUGS |
| CA2479665C (en) | 2002-03-20 | 2011-08-30 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
| GB2387781A (en) | 2002-04-25 | 2003-10-29 | Nektar Therapeutics Uk Ltd | Particulate materials |
| US20040092577A1 (en) | 2002-04-26 | 2004-05-13 | Lerner E. Itzhak | Microparticle pharmaceutical compositions for intratumoral delivery |
| US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
| CN1255394C (en) | 2002-06-24 | 2006-05-10 | 成都思摩纳米技术有限公司 | Process for the manufacture of pacilitaxel nano granule |
| KR100573289B1 (en) | 2002-07-20 | 2006-04-24 | 대화제약 주식회사 | Paclitaxel composition for the treatment of bladder cancer through intra-bladder administration and method for preparing the same |
| WO2004098570A1 (en)* | 2002-10-30 | 2004-11-18 | Spherics, Inc. | Nanoparticulate bioactive agents |
| KR100508518B1 (en) | 2002-11-13 | 2005-08-17 | 한미약품 주식회사 | Method for the preparation of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby |
| EP1585548B1 (en) | 2002-12-09 | 2018-06-27 | Abraxis BioScience, LLC | Compositions and methods of delivery of pharmacological agents |
| US7455797B2 (en) | 2003-02-28 | 2008-11-25 | Ferro Corporation | Method and apparatus for producing particles using supercritical fluid |
| WO2004089291A2 (en) | 2003-04-03 | 2004-10-21 | Au Jessie L-S | Tumor-targeting drug-loaded particles |
| US20060147535A1 (en) | 2003-04-16 | 2006-07-06 | Poongunran Muthukumaran | Methods for and compositions of anticancer medicaments |
| US20050059613A1 (en) | 2003-07-08 | 2005-03-17 | Bahram Memarzadeh | Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
| US8021831B2 (en) | 2003-08-25 | 2011-09-20 | Board Of Regents, The University Of Texas System | Taxane chemosensitivity prediction test |
| JP2007001865A (en) | 2003-09-16 | 2007-01-11 | Ltt Bio-Pharma Co Ltd | Fine particle enclosing fat-soluble medicine, method for producing the same and preparation containing the same |
| HUE028648T2 (en) | 2003-10-15 | 2016-12-28 | Syncore Biotechnology Co Ltd | Use of cationic liposomes comprising paclitaxel |
| WO2005042219A1 (en) | 2003-10-24 | 2005-05-12 | Ferro Corporation | Method of forming particles |
| JP4787165B2 (en)* | 2003-11-05 | 2011-10-05 | エラン ファーマ インターナショナル，リミティド | Nanoparticle compositions having peptides as surface stabilizers |
| GB0402963D0 (en) | 2004-02-11 | 2004-03-17 | Univ Nottingham | Counter current mixing device for two different fluids |
| US8043631B2 (en) | 2004-04-02 | 2011-10-25 | Au Jessie L S | Tumor targeting drug-loaded particles |
| JP5164381B2 (en) | 2004-10-29 | 2013-03-21 | 株式会社奈良機械製作所 | Granulation method of fine particles |
| CA2588442A1 (en) | 2004-12-14 | 2006-06-29 | Transave, Inc. | Lipid particles comprising bioactive agents, methods of preparing and uses thereof |
| ES2265262B1 (en) | 2005-01-31 | 2008-03-01 | Activery Biotech, S.L.(Titular Al 50%) | PROCEDURE FOR OBTAINING MICRO- AND NANODISPERSE SYSTEMS. |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| JP2008531591A (en)* | 2005-02-24 | 2008-08-14 | エラン・ファルマ・インターナショナル・リミテッド | Nanoparticulate formulations of docetaxel and their analogs |
| US7872050B2 (en) | 2005-03-14 | 2011-01-18 | Yaupon Therapeutics Inc. | Stabilized compositions of volatile alkylating agents and methods of using thereof |
| CA2602776C (en) | 2005-03-31 | 2013-10-22 | Lidds Ab | Method for treating prostate diseases based on local delivery of active substances |
| CN1923189A (en) | 2005-08-30 | 2007-03-07 | 孔庆忠 | Taxine kind anti-cancer slow release injection |
| EP1928435B8 (en) | 2005-08-31 | 2019-03-20 | Abraxis BioScience, LLC | Compositions of poorly water soluble drugs with increased stability and methods for preparation thereof |
| KR20080077680A (en) | 2005-12-11 | 2008-08-25 | 에스씨에프 테크놀로지스 에이/에스 | Method of Making Nano Size Materials |
| US8906392B2 (en) | 2005-12-16 | 2014-12-09 | University Of Kansas | Nanocluster compositions and methods |
| AR054215A1 (en) | 2006-01-20 | 2007-06-13 | Eriochem Sa | A PHARMACEUTICAL FORMULATION OF A TAXANE, A SOLID COMPOSITION OF A LIOFILIZED TAXAN FROM AN ACETIC ACID SOLUTION, A PROCEDURE FOR THE PREPARATION OF A SOLID COMPOSITION OF A TAXANE, A SOLUBILIZING COMPOSITION OF A LIOFILIZED TAXANE AND AN ELEMENTARY KIT |
| CN101336899A (en) | 2006-01-25 | 2009-01-07 | 济南帅华医药科技有限公司 | Anticancer sustained-released injection containing taxane |
| WO2007104549A2 (en) | 2006-03-14 | 2007-09-20 | Lidds Ab | Bioresorbable controlled-release composition |
| CN101460147A (en)* | 2006-04-03 | 2009-06-17 | 特瓦制药工业有限公司 | Drug microparticles |
| TW200817047A (en) | 2006-04-03 | 2008-04-16 | Teva Pharma | Drug microparticles |
| EP2476412B1 (en) | 2006-10-11 | 2014-03-19 | Crititech, Inc. | Apparatus for precipitation of small medicament particles into use containers |
| JP2010522207A (en) | 2007-03-23 | 2010-07-01 | エラン・ファルマ・インターナショナル・リミテッド | Gamma-irradiated sterile nanoparticulate docetaxel composition and method for making the composition |
| TWI405590B (en) | 2007-04-06 | 2013-08-21 | Activus Pharma Co Ltd | Method for preparing micro-pulverized organic compound particles |
| EP3326630A3 (en)* | 2007-05-03 | 2018-08-29 | Abraxis BioScience, LLC | Methods and compositions for treating pulmonary hypertension |
| AU2008259768B2 (en)* | 2007-06-05 | 2013-08-29 | Paka Pulmonary Pharmaceuticals, Inc. | Compositions for delivering medicaments into the lungs, uses thereof |
| EP2173732A4 (en) | 2007-07-04 | 2011-09-07 | Reddys Lab Ltd Dr | Docetaxel process and polymorphs |
| CN101129338A (en) | 2007-08-27 | 2008-02-27 | 四川大学 | Supercritical Fluid New Technology Miniaturizes Anticancer Drug Paclitaxel |
| CN104096236A (en) | 2008-03-06 | 2014-10-15 | 日东电工株式会社 | Polymer paclitaxel conjugates and methods for treating cancer |
| EP2345426B1 (en) | 2008-09-19 | 2014-03-05 | Activus Pharma Co., Ltd. | Composite organic compound powder for medical use, method for producing same and suspension of same |
| CN105999297A (en) | 2008-12-02 | 2016-10-12 | 生物相容英国有限公司 | Pancreatic tumour treatment |
| PT104693B (en) | 2009-07-27 | 2011-11-24 | Univ Lisboa | SEMI-SOLID LIPID NANOPARTICLES CONTAINING AN ANTINEOPLASTIC AGENT AND ITS PREPARATION PROCESS |
| JP2013502235A (en) | 2009-08-24 | 2013-01-24 | ベイラー カレッジ オブ メディスン | Generation of specific CTL lines against multiple tumor antigens or viruses [cross-reference of related applications] |
| US8623329B1 (en) | 2009-10-13 | 2014-01-07 | Aerophase, Inc. | Method for the treatment of lung tumors |
| CN102091062A (en)* | 2009-12-11 | 2011-06-15 | 国家纳米技术与工程研究院 | Method for treating lung cancer by sucking and administrating taxol |
| CN101829061A (en) | 2010-05-14 | 2010-09-15 | 无锡纳生生物科技有限公司 | Taxol nanoparticle composition and preparation method thereof |
| AU2011261684B2 (en) | 2010-06-02 | 2016-09-15 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| ES2776983T3 (en) | 2010-09-21 | 2020-08-03 | Cristal Delivery B V | Tunable biodegradable linker molecules for transient conjugation of components in drug delivery systems, and drug delivery systems prepared therewith |
| JP2014504260A (en) | 2010-10-15 | 2014-02-20 | グラクソ グループ リミテッド | Aggregated nanoparticulate drug formulation, its manufacture and use |
| WO2012096995A2 (en) | 2011-01-11 | 2012-07-19 | Boston Scientific Scimed, Inc. | Coated medical devices |
| WO2012142669A1 (en) | 2011-04-20 | 2012-10-26 | The University Of Sydney | A method for the treatment of a solid tumour |
| WO2013052158A2 (en) | 2011-04-26 | 2013-04-11 | William Marsh Rice University | Targeted nanovectors and their use for treatment of brain tumors |
| MX369543B (en) | 2011-06-17 | 2019-11-12 | Berg Llc | Inhalable pharmaceutical compositions. |
| CN103764172A (en) | 2011-06-27 | 2014-04-30 | 科里斯塔鲁传送有限公司 | Controlled release system |
| FR2980683B1 (en)* | 2011-09-30 | 2014-11-21 | Univ Paris Curie | DEVICE FOR GUIDING A MEDICAL INSTRUMENT INSERTED IN A NATURAL PATH OR AN ARTIFICIAL PATH OF A PATIENT |
| CN102488682A (en) | 2011-11-22 | 2012-06-13 | 四川九章生物化工科技发展有限公司 | New application of chlorogenic acid in cancer resisting |
| US10555911B2 (en) | 2012-05-04 | 2020-02-11 | Yale University | Highly penetrative nanocarriers for treatment of CNS disease |
| TW201408304A (en) | 2012-08-31 | 2014-03-01 | Cathay General Hospital | A combined drug with anti-cancer drug and hormone to treat renal cell carcinoma and its method of fabrication |
| SG11201501850VA (en) | 2012-09-21 | 2015-04-29 | Intensity Therapeutics Inc | Method of treating cancer |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| MX345183B (en) | 2013-02-28 | 2017-01-05 | Pfizer | Enhanced stability of novel liquid compositions. |
| US8778181B1 (en)* | 2013-03-14 | 2014-07-15 | Crititech, Inc. | Equipment assembly for and method of processing particles |
| US9925512B2 (en) | 2013-03-14 | 2018-03-27 | Crititech, Inc. | Equipment assembly for and method of processing particles |
| EP2978420A4 (en) | 2013-03-28 | 2016-12-21 | Bbs Nanotechnology Ltd | STABLE NANOCOMPOSITION COMPRISING PACLITAXEL, PROCESS FOR ITS PREPARATION, USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| CA2944480C (en) | 2013-04-10 | 2021-05-18 | Massachusetts Institute Of Technology | Local drug delivery devices and methods for treating cancer |
| EP3057619A1 (en) | 2013-10-16 | 2016-08-24 | Université Libre de Bruxelles | Formulations useful in the treatment of proliferative diseases affecting the respiratory tract |
| AU2014364601A1 (en) | 2013-12-17 | 2016-07-07 | Genentech, Inc. | Methods of treating HER2-positive cancers using PD-1 axis binding antagonists and anti-HER2 antibodies |
| EP3082853A2 (en) | 2013-12-20 | 2016-10-26 | The Broad Institute, Inc. | Combination therapy with neoantigen vaccine |
| WO2015103005A1 (en) | 2014-01-03 | 2015-07-09 | Research Institute At Nationwide Children's Hospital | Amphiphilic amine compounds and their use as therapeutic agents and nanocarriers |
| TWI601542B (en)* | 2014-04-18 | 2017-10-11 | 林信湧 | Inhalation-type pharmaceutical composition for lung cancer and preparation method thereof |
| WO2015187194A1 (en) | 2014-06-01 | 2015-12-10 | Crititech, Inc. | Use of paclitaxel particles |
| US11033620B2 (en) | 2014-06-09 | 2021-06-15 | Biomed Valley Discoveries, Inc. | Combination therapies targeting tumor-associated stroma or tumor cells and microtubules |
| EP3234193B1 (en) | 2014-12-19 | 2020-07-15 | Massachusetts Institute of Technology | Molecular biomarkers for cancer immunotherapy |
| EP3302431B1 (en) | 2015-06-04 | 2020-11-11 | Crititech, Inc. | Taxane particles and their use |
| CN108778244B (en) | 2015-09-16 | 2022-04-01 | Dfb索里亚有限责任公司 | Delivery of drug nanoparticles and methods of use thereof |
| KR20180058759A (en) | 2015-09-25 | 2018-06-01 | 제트와이 테라퓨틱스 인코포레이티드 | Pharmaceutical preparations based on microparticles comprising a polysaccharide-vitamin conjugate |
| DE202016006620U1 (en) | 2015-10-28 | 2017-04-12 | Qass Gmbh | Devices for observing a magnetic field of a material volume |
| US11096964B2 (en) | 2016-01-20 | 2021-08-24 | Fate Therapeutics, Inc. | Compositions and methods for immune cell modulation in adoptive immunotherapies |
| BR112018069628A2 (en) | 2016-04-04 | 2019-02-12 | Crititech, Inc. | solid tumor treatment methods |
| CN107281502B (en) | 2016-04-05 | 2021-05-04 | 上海市肿瘤研究所 | A kind of compound developing thermosensitive gel embolic agent, preparation method and application thereof |
| US10894093B2 (en) | 2016-04-15 | 2021-01-19 | Cellectis | Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation |
| US9567399B1 (en) | 2016-06-20 | 2017-02-14 | Kymab Limited | Antibodies and immunocytokines |
| EP3506942B1 (en) | 2016-09-01 | 2022-11-16 | Mayo Foundation for Medical Education and Research | Carrier-pd-l1 binding agent compositions for treating cancers |
| WO2018170196A1 (en) | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes |
| WO2018170207A1 (en) | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of skin keratoses using nanoparticles of taxanes |
| WO2018170210A1 (en) | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of vulvar intraepithelial neoplasia (vin) and genital warts using nanoparticles of taxanes |
| WO2018227037A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| CA3063436A1 (en)* | 2017-06-14 | 2018-12-20 | Crititech, Inc. | Methods for treating lung disorders |
| CA3076919A1 (en)* | 2017-10-03 | 2019-04-11 | Crititech, Inc. | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
| SG11202008749UA (en)* | 2018-05-31 | 2020-10-29 | Crititech Inc | Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccines |
| Publication number | Publication date |
|---|---|
| AU2018284247A1 (en) | 2019-11-07 |
| AU2020204217B2 (en) | 2021-11-18 |
| KR20200015479A (en) | 2020-02-12 |
| JP6840869B2 (en) | 2021-03-10 |
| AU2018284247B2 (en) | 2020-04-30 |
| BR112019022720A2 (en) | 2020-05-12 |
| CN115919815A (en) | 2023-04-07 |
| US10398646B2 (en) | 2019-09-03 |
| CN110799176A (en) | 2020-02-14 |
| US10507181B2 (en) | 2019-12-17 |
| US11160754B2 (en) | 2021-11-02 |
| AU2020204217A1 (en) | 2020-07-16 |
| JP2020523286A (en) | 2020-08-06 |
| RU2019134091A3 (en) | 2021-11-08 |
| RU2019134091A (en) | 2021-07-14 |
| US20180360748A1 (en) | 2018-12-20 |
| KR20210118468A (en) | 2021-09-30 |
| ES3015106T3 (en) | 2025-04-29 |
| SG10201913400QA (en) | 2020-03-30 |
| EP3615004A1 (en) | 2020-03-04 |
| CA3063436A1 (en) | 2018-12-20 |
| US20190314277A1 (en) | 2019-10-17 |
| EP3615004B1 (en) | 2025-02-19 |
| US20200060969A1 (en) | 2020-02-27 |
| JP2021075571A (en) | 2021-05-20 |
| WO2018231908A1 (en) | 2018-12-20 |
| KR102303762B1 (en) | 2021-09-23 |
| Publication | Publication Date | Title |
|---|---|---|
| SG11201909837YA (en) | Methods for treating lung disorders | |
| SG11201808125RA (en) | Methods for solid tumor treatment | |
| SG11201811432WA (en) | Rna for cancer therapy | |
| SG11201908813QA (en) | Anti-sirp alpha antibodies | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201804901WA (en) | Compounds for the treatment of cancer and inflammatory disease | |
| SG11201901126UA (en) | Combination therapy for cancer | |
| SG11201900028VA (en) | Crispr/cas9-based compositions and methods for treating cancer | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201808913WA (en) | Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancer | |
| SG11201805645QA (en) | Lsd1 inhibitors | |
| SG11201803906PA (en) | Control of cellular redox levels | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201803920TA (en) | Compounds and compositions useful for treating disorders related to ntrk | |
| SG11201909840TA (en) | Treatment of epithelial cysts by intracystic injection of antineoplastic particles | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201804770QA (en) | Method and arrangement for recovery of salt | |
| SG11201805149XA (en) | Compositions comprising 15-hepe and methods of using the same | |
| SG11201810940XA (en) | Methods of treating pancreatic cancer | |
| SG11201810853UA (en) | Anti-tnfrsf25 antibodies | |
| SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones |